Key Events This Week
18 May: Intraday low hit amid significant price pressure (Rs.723.95)
18 May: Technical momentum shifts to mildly bearish stance
19 May: Recovery attempt with 3.85% gain
22 May: Week closes at Rs.755.45, down 3.73%
18 May 2026: Intraday Low Amid Price Pressure
On 18 May, Alembic Pharmaceuticals Ltd. faced significant selling pressure, closing at Rs.723.95, a sharp decline of 7.74% from the previous close. The stock touched an intraday low of Rs.728, marking a 7.23% drop intraday. This underperformance was notable against the Sensex’s relatively mild 0.35% decline to 35,114.86. The stock’s fall extended a losing streak, with prices trading below key moving averages such as the 5-day, 20-day, 100-day, and 200-day, signalling short- to medium-term bearish momentum despite remaining above the 50-day average.
This price weakness coincided with a broadly negative market environment, where the Sensex was trading near its 52-week lows. Alembic’s losses outpaced sector averages, highlighting company-specific challenges amid the broader downturn. The stock’s Mojo Score of 42.0, categorised as a 'Sell', reflects this deteriorating technical and fundamental outlook.
Technical Momentum Shifts to Mildly Bearish
Also on 18 May, technical analysis revealed a shift in Alembic Pharmaceuticals’ momentum from sideways to mildly bearish. Daily moving averages indicated downward pressure, while weekly MACD remained mildly bullish, contrasting with a bearish monthly MACD. This divergence suggested short-term opportunities tempered by longer-term caution.
RSI readings hovered neutrally, indicating no strong overbought or oversold conditions. Bollinger Bands showed mild bullishness weekly but bearishness monthly, reinforcing the mixed signals. The Know Sure Thing (KST) indicator and Dow Theory assessments also presented conflicting views, with weekly mild bullishness offset by monthly bearishness.
On-Balance Volume (OBV) readings were bullish on both weekly and monthly charts, suggesting underlying accumulation despite price softness. This complex technical profile underscored the stock’s uncertain near-term trajectory.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
19 May 2026: Recovery Attempt with 3.85% Gain
Following the sharp decline, Alembic Pharmaceuticals rebounded on 19 May, closing at Rs.751.85, up 3.85% on the day. This recovery outpaced the Sensex’s 0.25% gain to 35,201.48, signalling a short-term bounce amid stabilising market conditions. Volume declined from the previous day’s 20,389 shares to 15,570, indicating cautious participation.
The stock’s ability to regain some ground after the steep fall suggested that some investors viewed the lower price levels as a buying opportunity, although the overall weekly trend remained negative.
20-22 May 2026: Consolidation and Mild Volatility
On 20 May, Alembic Pharmaceuticals closed marginally higher at Rs.752.70 (+0.11%), with the Sensex advancing 0.28%. The following day, 21 May, the stock slipped slightly by 0.67% to Rs.747.65, while the Sensex continued its upward trend with a 0.12% gain. On the final trading day, 22 May, the stock rose 1.04% to Rs.755.45, yet this was insufficient to offset the week’s losses.
Throughout these days, volumes steadily declined, reaching 6,847 shares on 22 May, reflecting subdued trading interest amid mixed technical signals. The stock remained below key moving averages, maintaining a cautious outlook despite minor intraday recoveries.
Holding Alembic Pharmaceuticals Ltd. from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-05-18 | Rs.723.95 | -7.74% | 35,114.86 | -0.35% |
| 2026-05-19 | Rs.751.85 | +3.85% | 35,201.48 | +0.25% |
| 2026-05-20 | Rs.752.70 | +0.11% | 35,299.20 | +0.28% |
| 2026-05-21 | Rs.747.65 | -0.67% | 35,340.31 | +0.12% |
| 2026-05-22 | Rs.755.45 | +1.04% | 35,413.94 | +0.21% |
Key Takeaways
Price Pressure and Volatility: Alembic Pharmaceuticals experienced significant price pressure early in the week, with a steep 7.74% drop on 18 May, followed by a partial recovery. The stock’s weekly decline of 3.73% contrasted with the Sensex’s 0.50% gain, indicating relative underperformance amid a volatile market.
Mixed Technical Signals: Technical indicators presented a complex picture. Weekly momentum oscillators such as MACD and KST showed mild bullishness, while monthly indicators suggested bearishness. The stock’s position below key moving averages and a 'Sell' Mojo Grade underscore caution.
Volume and Market Participation: Declining volumes through the week suggest reduced trading interest, which may limit price momentum. However, bullish On-Balance Volume readings indicate some underlying accumulation, potentially providing support.
Sector and Market Context: Alembic’s underperformance relative to the Sensex and sector averages highlights company-specific challenges amid a cautious broader market environment. The small-cap classification adds to volatility risks.
Conclusion
Alembic Pharmaceuticals Ltd. faced a challenging week marked by significant early losses and a mixed technical outlook. Despite some recovery attempts, the stock closed the week down 3.73%, underperforming the Sensex’s modest gains. Technical momentum remains conflicted, with short-term indicators offering mild optimism but longer-term signals and moving averages suggesting caution. Volume trends and the 'Sell' Mojo Grade reinforce the need for vigilance. Investors should monitor key support levels and broader market developments closely as Alembic navigates this uncertain phase.
Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →
